JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
+$1.58B |
| 2 |
Vanguard FTSE Europe ETF
VGK
|
+$1B |
| 3 |
CPGX
COLUMBIA PIPELINE GROUP IN COM STK (DE)
CPGX
|
+$958M |
| 4 |
Eli Lilly
LLY
|
+$776M |
| 5 |
AGN
Allergan plc
AGN
|
+$751M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.23B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.98B |
| 3 |
Johnson & Johnson
JNJ
|
+$1.31B |
| 4 |
Merck
MRK
|
+$837M |
| 5 |
Bread Financial
BFH
|
+$630M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.93% |
| 2 | Healthcare | 11.41% |
| 3 | Technology | 10.89% |
| 4 | Consumer Discretionary | 8.56% |
| 5 | Industrials | 7.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AEL
1101
DELISTED
American Equity Investment Life Holding Company
AEL
| $25M | 0.01% |
1,073,348
-773,875
| -42% | -$19.9M |
|
|
ANAC
1102
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $25M | 0.01% |
212,317
+53,549
| +34% | +$6.99M |
|
1103
Ziff Davis
ZD
$1.97B
| $24.9M | 0.01% |
404,586
+140,456
| +53% | +$8.51M |
|
1104
H&R Block
HRB
$5.92B
| $24.8M | 0.01% |
685,662
-563,968
| -45% | -$19.1M |
|
|
NIHD
1105
DELISTED
NII Holdings, Inc. Common Stock
NIHD
| $24.8M | 0.01% |
+3,808,592
| New | +$41.6M |
|
|
MDCO
1106
DELISTED
Medicines Co
MDCO
| $24.7M | 0.01% |
651,224
-113,884
| -15% | -$4M |
|
|
GHL
1107
DELISTED
Greenhill & Co., Inc.
GHL
| $24.7M | 0.01% |
867,147
+22,056
| +3% | +$810K |
|
1108
NetApp
NTAP
$38.9B
| $24.7M | 0.01% |
833,864
-425,526
| -34% | -$13.1M |
|
1109
CALL
Union Pacific
UNP
$174B
| $24.6M | 0.01% |
278,500
| – | – |
|
1110
Avnet
AVT
$7.87B
| $24.6M | 0.01% |
576,785
+35,530
| +7% | +$1.48M |
|
1111
Monarch Casino & Resort
MCRI
$2.19B
| $24.6M | 0.01% |
1,367,536
-322
| -0% | -$6.06K |
|
1112
BGC Group
BGC
$4.8B
| $24.6M | 0.01% |
4,647,895
-197,614
| -4% | -$1.15M |
|
1113
MKS Inc
MKSI
$19.9B
| $24.5M | 0.01% |
730,464
-44,939
| -6% | -$1.56M |
|
1114
Spire
SR
$4.87B
| $24.5M | 0.01% |
448,693
-128,983
| -22% | -$6.86M |
|
1115
PUT
Thermo Fisher Scientific
TMO
$224B
| $24.5M | 0.01% |
200,000
| – | – |
|
|
FMER
1116
DELISTED
FIRSTMERIT CORP
FMER
| $24.3M | 0.01% |
1,375,797
-139,132
| -9% | -$2.61M |
|
1117
United Therapeutics
UTHR
$22.1B
| $24.2M | 0.01% |
184,266
-669
| -0.4% | -$107K |
|
1118
Tyler Technologies
TYL
$13.2B
| $24.1M | 0.01% |
161,742
+25,047
| +18% | +$3.52M |
|
1119
PUT
Macy's
M
$6.45B
| $24.1M | 0.01% |
470,100
+369,500
| +367% | +$23.2M |
|
|
RKUS
1120
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
| $24.1M | 0.01% |
2,029,323
+1,065
| +0.1% | +$12K |
|
1121
Bank of Montreal
BMO
$127B
| $24.1M | 0.01% |
441,922
-217,677
| -33% | -$12M |
|
1122
Saic
SAIC
$5.3B
| $24.1M | 0.01% |
599,302
+7,701
| +1% | +$374K |
|
1123
CALL
Exelon
EXC
$46.2B
| $24M | 0.01% |
1,130,853
+1,121,600
| +12,121% | +$25.2M |
|
1124
Telefônica Brasil
VIV
$18.6B
| $23.9M | 0.01% |
2,622,499
+1,295,757
| +98% | +$15.2M |
|
|
AVTA
1125
DELISTED
Avantax, Inc. Common Stock
AVTA
| $23.9M | 0.01% |
1,734,511
+168,250
| +11% | +$2.41M |
|
Similar funds
JP Morgan Chase's Q3 2015 Portfolio in Review
As of Q3 2015, JP Morgan Chase held 4,367 positions worth $374B, down 12% from $424B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase withdrew a net $14B in Q3 2015, closing 488 positions and reducing 1,582 holdings. Its most notable exit was ROCK-TENN COMPANY CL-A, an estimated $559M position sold in full.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.
Against the trend, JP Morgan Chase opened a new position in COLUMBIA PIPELINE GROUP IN COM STK (DE) worth $672M.
- JP Morgan Chase's largest Q3 2015 buy was COLUMBIA PIPELINE GROUP IN COM STK (DE): 36,762,567 shares worth $672M.
- JP Morgan Chase added most to Xtrackers MSCI EAFE Hedged Equity ETF in Q3 2015, an estimated $1.58B increase.
- JP Morgan Chase's biggest Q3 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.23B.
- JP Morgan Chase fully exited ROCK-TENN COMPANY CL-A in Q3 2015, selling an estimated $559M.
- JP Morgan Chase's ten largest holdings make up 17% of its $374B portfolio in Q3 2015.
- JP Morgan Chase opened 374 new positions and closed 488 in Q3 2015.
- JP Morgan Chase's portfolio value fell 12% quarter-over-quarter to $374B.
Based on JP Morgan Chase's 13F filing for Q3 2015, filed 13 Nov 2015.